CSF proteomics analysis to investigate the pharmacodynamic response of the S2R modulator CT1812 in Alzheimer’s disease patients from the SPARC clinical trial

Authors :: Kiran Pandey
Lora Waybright
Duc M. Duong
Evi Malagise
Kaj Blennow
Henrik Zetterberg
Adam P Mecca
Christopher H van Dyck
Anthony O Caggiano
Nicholas T. Seyfried
Mary E Hamby
Source :: Alzheimer's & Dementia. 18
Publication Year :: 2022
Publisher :: Wiley, 2022.

Subjects :: Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Epidemiology
Health Policy
Neurology (clinical)
Geriatrics and Gerontology

Tools